| Title | Author(s) | Year | View Count |
 | Four years of lamivudine treatment in Chinese patients with chronic hepatitis B | Chang, TT; Lai, CL; Chien, RN; Guan, R; Lim, SG; Lee, CM; Ng, KY; Nicholls, GJ; Dent, JC; Leung, NWY | 2004 | 129 |
 | Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatiits B e antigen seroconversion rate: results after 3 years of therapy | Leung, NW; Lai, CL; Chang, TT; Guan, R; Lee, CM; Ng, KY; Lim, SG; Wu, PC; Dent, JC; Edmundson, S; Condreay, LD; Chien, RN | 2001 | 115 |
| Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy | Leung, NWY; Lai, CL; Chang, TT; Guan, R; Lee, CM; Ng, KY; Lim, SG; Wu, PC; Dent, JC; Edmundson, S; Condreay, LD; Chien, RN | 2001 | 61 |
 | A one-year trial of lamivudine for chronic hepatitis B | Lai, CL; Chien, RN; Leung, NWY; Chang, TT; Guan, R; Tai, DI; Ng, KY; Wu, PC; Dent, JC; Barber, J; Stephenson, SL; Gray, DF | 1998 | 322 |
| 12 months lamivudine (100mg od) therapy improves liver histology: results of a placebo controlled multicentre study in Asia | Lai, CL; Liaw, YF; Leung, NWY; Chang, TT; Guan, R; Tai, DI; Ng, KY; Wu, PC; Dent, JC; Gray, DF | 1997 | 207 |
| Short term lamivudine suppresses HBV DNA in Chinese HBsAg carriers | Lai, CL; Ching, CK; Tung, A; Hill, AM; Wong, BCY; Lim, SP; Dent, JC; Wu, PC | 1994 | 81 |
|
